Chamber Finds Drug Price Measures Will Stifle Research
By Kelly Lienhard · December 11, 2023, 9:05 PM EST
The U.S. Chamber of Commerce on Monday released a study examining clinical trial data that indicated the Biden administration's proposal to seize drug patents if the price is deemed unreasonable would...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login